Guideline for the use of intravenous immunoglobulin and plasma exchange in treatment of autoimmune neuromuscular disorders

Abstract

Guideline of treatment in Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, multifocal motor neuropathy, myasthenia gravis, dermatomyositis and polymyositis with intravenous immunoglobulin and plasma exchange.

Keywords

• autoimmune neuromuscular disorders